Home > Report on the risk assessment of 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) in the framework of the Council Decision on new psychoactive substances. Risk Assessments.

European Monitoring Centre for Drugs and Drug Addiction. (2018) Report on the risk assessment of 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl) in the framework of the Council Decision on new psychoactive substances. Risk Assessments. Luxembourg: Publications Office of the European Union. 58 p.

[img]
Preview
PDF (methoxyacetylfentanyl) - Published Version
799kB

This publication presents the data and findings of the risk assessment on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 27 September 2018, the Council decided that methoxyacetylfentanyl should be subject to control measures across the Member States.

Item Type:Evidence resource
Publication Type:Report
Drug Type:New psychoactive substance
Date:September 2018
Pages:58 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Subjects:B Substances > New (novel) psychoactive substances
J Health care, prevention and rehabilitation > Risk and needs assessment > Risk assessment
VA Geographic area > Europe

Repository Staff Only: item control page